New concepts regarding the medical care of AIDS patients are described
in this paper Currently, new pharmacologic agents and their combinati
ons with zidovudine are being evaluated in clinical trials to determin
e their efficacy in the treatment of HN-infected patients. Nevertheles
s, zidovudine is still the mainstay of therapy in AIDS patients. Signi
ficant findings regarding monotherapy, combination therapy and immunot
herapy for the treatment of HIV-infection are also discussed. There is
considerable controversy on the optimal time to initiate therapy with
antiretroviral agents. The clinician's decision To initiate antiretro
viral therapy should consider the expectations of patients in the cont
ext of relative benefits and potential toxicities of therapy. The clin
ician must be aware that rigid universal therapy guidelines for all pa
tients may not be appropriate. Currently available drugs are only pall
iative and the development of innovative therapeutic strategies for ea
rly intervention is indispensable on the basis of recent knowledge of
the extremely complex pathogenesis of HN infection. At present time, t
he medical care of AIDS patients should be individualized and done in
the context of the patient-physician relationship for therapeutic and
nontherapeutic decisions.